NIH 2008 N01 HL |
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension / University of Illinois at Chicago |
$344,995 |
NIH 2007 N01 HL |
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension Schraufnagel, Dean / |
$292,732 |
NIH 2007 N01 HL |
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension / |
|